Acambis PLC - ACAM2000 BLA Completed

Acambis plc ("Acambis") (LSE: ACM, NASDAQ: ACAM) announces that it has completed submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) to seek licensure of its investigational smallpox vaccine, ACAM2000.